Reaction Details  Report a problem with these data
Target
Glucagon-like peptide 1 receptor
Ligand
BDBM50007240
Substrate
n/a
Meas. Tech.
ChEMBL_1338730 (CHEMBL3242201)
IC50
>10000±n/a nM
Citation
 DeMong, D; Dai, X; Hwa, J; Miller, M; Lin, SI; Kang, L; Stamford, A; Greenlee, W; Yu, W; Wong, M; Lavey, B; Kozlowski, J; Zhou, G; Yang, DY; Patel, B; Soriano, A; Zhai, Y; Sondey, C; Zhang, H; Lachowicz, J; Grotz, D; Cox, K; Morrison, R; Andreani, T; Cao, Y; Liang, M; Meng, T; McNamara, P; Wong, J; Bradley, P; Feng, KI; Belani, J; Chen, P; Dai, P; Gauuan, J; Lin, P; Zhao, H The discovery of N-((2H-tetrazol-5-yl)methyl)-4-((R)-1-((5r,8R)-8-(tert-butyl)-3-(3,5-dichlorophenyl)-2-oxo-1,4-diazaspiro[4.5]dec-3-en-1-yl)-4,4-dimethylpentyl)benzamide (SCH 900822): a potent and selective glucagon receptor antagonist. J Med Chem 57:2601-10 (2014) [PubMed]  Article
Target
Name:
Glucagon-like peptide 1 receptor
Synonyms:
GLP-1 receptor | GLP-1-R | GLP-1R | GLP1R | GLP1R_HUMAN | Glucagon-like peptide 1 receptor | Glucagon-like peptide 1 receptor (GLP-1)
Type:
Enzyme
Mol. Mass.:
53035.78
Organism:
Homo sapiens (Human)
Description:
P43220
Residue:
463
Sequence:
MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS
  
Inhibitor
Name:
BDBM50007240
Synonyms:
CHEMBL3238228
Type:
Small organic molecule
Emp. Form.:
C34H43F3N8O2
Mol. Mass.:
652.7528
SMILES:
CC(C)(C)CC[C@@H](N1C(=O)C(=N[C@@]11CC[C@@H](CC1)C(C)(C)C)c1cnccc1C(F)(F)F)c1ccc(cc1)C(=O)NCc1nn[nH]n1 |r,wU:15.19,6.5,wD:12.13,c:10,(5.79,-14.06,;5.77,-12.52,;4.43,-11.77,;4.43,-13.28,;7.1,-11.73,;7.08,-10.19,;8.4,-9.41,;8.35,-7.87,;9.56,-6.92,;11.04,-7.34,;9.03,-5.47,;7.48,-5.53,;7.07,-7.01,;5.88,-6.03,;4.43,-6.56,;4.17,-8.08,;5.36,-9.06,;6.8,-8.53,;2.73,-8.61,;1.55,-7.62,;1.28,-9.14,;2.47,-10.13,;9.8,-4.14,;11.34,-4.16,;12.12,-2.83,;11.36,-1.48,;9.82,-1.48,;9.04,-2.81,;7.5,-2.8,;6.74,-1.47,;6.72,-4.13,;5.96,-2.79,;9.73,-10.19,;9.7,-11.74,;11.03,-12.52,;12.38,-11.77,;12.4,-10.23,;11.07,-9.45,;13.7,-12.56,;13.68,-14.1,;15.04,-11.81,;16.36,-12.59,;17.71,-11.84,;19.1,-12.48,;20.15,-11.34,;19.39,-10,;17.88,-10.31,)|
Structure:
Search PDB for entries with ligand similarity: